Serum lipopotein (a) levels in a large sample of subjects affected by familial combined hyperlipoproteinaemia and in general population

被引:6
作者
Cicero, AFG [1 ]
Panourgia, MP [1 ]
Linarello, S [1 ]
D'Addato, S [1 ]
Sangiorgi, Z [1 ]
Gaddi, A [1 ]
机构
[1] Policlin S Orsola, Clin Med & Appl Biotechnol Dept D Campanacci, Atherosclerosis Study Ctr G Descovich, I-40138 Bologna, Italy
来源
JOURNAL OF CARDIOVASCULAR RISK | 2003年 / 10卷 / 02期
关键词
familial combined hyperlipoproteinaemia; lipoprotein(a); dyslipidaemias; risk factor; premature coronary heart disease;
D O I
10.1097/00043798-200304000-00011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Serum lipoprotein (a) [Lp(a)] is a lipidic parameter, strictly under genetic control. Lp(a) levels vary in different dyslipidaemias according to the underlying disease. Design The aim of this study was to evaluate and compare serum Lp(a) mean levels distribution in a large familial combined hyperlipoproteinaemia (FCH) patients sample with a normolipidaemic group. Methods FCH group included 138 subjects (74 males and 65 females) aged from 16 to 88 years; the control group included 438 normolipidaemic subjects (238 males and 200 females) aged from 16 to 91 years. In both groups we have measured Lp(a) concentrations and other lipidic parameters. Results Serum lipid levels as well as Lp(a) log-transformed concentrations were on average higher in FCH patients than in control subjects. Lp(a) concentrations were not significantly different between sexes and among 20-year age classes in both groups. Conclusions The relationship between FCH and Lp(a) remains controversial. However, since both are considered independent risk factors for premature CHD development, even if their pathogenic interaction is still unclear, we suggest that Lp(a) values should be carefully monitored in dyslipidaemic subjects and particularly in FCH ones. In FCH subjects with elevated Lp(a) levels, aggressive intervention could be required. (C) 2003 Lippincott Williams Wilkins.
引用
收藏
页码:149 / 151
页数:3
相关论文
共 15 条
[1]   LP(A) LEVELS IN DIFFERENT TYPES OF DYSLIPIDEMIA IN THE FRENCH POPULATION [J].
BOYER, H ;
DEGENNES, JL ;
TRUFFERT, J ;
CHATELLIER, G ;
DAIROU, F ;
BRUCKERT, E .
ATHEROSCLEROSIS, 1990, 85 (01) :61-69
[2]   A suggestion for familial hypercholesterolemia (FH) heterozygosity clinical diagnosis based on epidemiological observations in a large Italian population [J].
Cicero, AFG ;
Braiato, A ;
D'Addato, S ;
Sangiorgi, Z ;
Gaddi, A .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2000, 74 (01) :5-11
[3]   Lipoprotein (a) concentrations in patients with various dyslipidaemias [J].
Elisaf, MS ;
Bairaktari, ET ;
Tzallas, CS ;
Siamopoulos, KC .
ANNALS OF MEDICINE, 1997, 29 (04) :305-309
[4]   LIPOPROTEIN(A) SERUM CONCENTRATION IN FAMILIAL COMBINED HYPERLIPIDEMIA [J].
FONDA, M ;
DACOL, PG ;
LAVERDE, R ;
BATTELLO, C ;
FISICARO, M ;
TONIZZO, M ;
CATTIN, L .
CLINICA CHIMICA ACTA, 1993, 223 (1-2) :121-127
[5]  
Gaddi A, 1999, NUTR METAB CARDIOVAS, V9, P304
[6]  
Gaw Allan, 1994, Current Opinion in Lipidology, V5, P149, DOI 10.1097/00041433-199404000-00012
[7]   FAMILIAL LIPOPROTEIN DISORDERS IN PATIENTS WITH PREMATURE CORONARY-ARTERY DISEASE [J].
GENEST, JJ ;
MARTINMUNLEY, SS ;
MCNAMARA, JR ;
ORDOVAS, JM ;
JENNER, J ;
MYERS, RH ;
SILBERMAN, SR ;
WILSON, PWF ;
SALEM, DN ;
SCHAEFER, EJ .
CIRCULATION, 1992, 85 (06) :2025-2033
[8]   PLASMA LIPOPROTEIN(A) CONCENTRATION IN FAMILIAL HYPERCHOLESTEROLEMIC PATIENTS WITHOUT CORONARY-ARTERY DISEASE [J].
GHISELLI, G ;
GADDI, A ;
BAROZZI, G ;
CIARROCCHI, A ;
DESCOVICH, G .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (08) :833-838
[9]   Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease - Results from the NHLBI Family Heart Study [J].
Hopkins, PN ;
Hunt, SC ;
Schreiner, PJ ;
Eckfeldt, JH ;
Borecki, IB ;
Ellison, CR ;
Williams, RR ;
Siegmund, KD .
ATHEROSCLEROSIS, 1998, 141 (02) :333-345
[10]   Lipoprotein(a) interactions with lipid and nonlipid risk factors in early familial coronary artery disease [J].
Hopkins, PN ;
Wu, LL ;
Hunt, SC ;
James, BC ;
Vincent, GM ;
Williams, RR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) :2783-2792